Aimil Pharmaceuticals(India) Limited, a active public limited company, was established on 30 November 1984 in New Delhi, Delhi, India. Engaging in ayurvedic products & services within the manufacturing sector, it holds CIN: U24231DL1984PLC019461. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹14.50 Cr and a paid-up capital of ₹11.55 Cr.
Formerly known as Aimil Pharmaceuticals India Private Limited. It upholds a compliant status. Employing 195 professional, Its leadership includes Ikshit Sharma (Director), Sanchit Sharma (Additional Director), Kanwal Kumar Sharma (Managing Director). Past directors included Varinder Pall Singh, Ikshit Sharma, Subhash Sharma. It holds ₹94.34 Cr open charges and ₹24.00 Cr settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at 2994/4 Street No 17Ranjeet Nagar, New Delhi, Delhi, 110008.
U24231DL1984PLC019461
019461
30 November 1984
₹14.50 Cr
₹11.55 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Aimil Pharmaceuticals(India) Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ikshit Sharma | Director | 21 Nov 2019 | Current |
| Sanchit Sharma | Additional Director | 12 Feb 2025 | Current |
| Kanwal Kumar Sharma | Managing Director | 30 Nov 1984 | Current |
| Pankaj Marwaha | Director | 26 Sep 1988 | Current |
| Satya Prakash Shrivastava | Director | 18 Aug 2014 | Current |
| Manjula Sharma | Director | 24 Jul 1996 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Nominee Director | 19 Apr 2016 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Director | 24 May 2019 | Past |
| Pramod Abcsdd | Additional Director | 25 Sep 2014 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Cfo | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Aimil Pharmaceuticals(India) Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.39% increase. The company also saw a substantial improvement in profitability, with a 41.07% increase in profit. The company's net worth Soared by an impressive increase of 11.95%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Aimil Pharmaceuticals(India) had a promoter holding of 96.44% and a public holding of 3.57%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹943,415,726.00
₹240,047,500.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Sep 2023 | Tata Capital Financial Services Limited | ₹1.75 Cr | Open |
| 29 Oct 2021 | Others | ₹13.75 Cr | Open |
| 08 Oct 2021 | Others | ₹3.48 M | Open |
| 14 Oct 2019 | Others | ₹8.35 M | Open |
| 04 Jan 2017 | Others | ₹1.59 M | Open |
Explore comprehensive loan charge details -
Aimil Pharmaceuticals(India) has a workforce of 195 employees as of Jan 09, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Aimil Pharmaceuticals(India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aimil Pharmaceuticals(India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge registered on 23 Jun 2021 via Charge ID 100458782 with Others was fully satisfied on 22 Apr 2025. was recorded as a recent event.
The activity A charge registered on 19 Mar 2018 via Charge ID 100186755 with Others was fully satisfied on 22 Apr 2025. was completed.
Progress on A charge registered on 28 Feb 2014 via Charge ID 10482863 with Punjab National Bank was fully satisfied on 22 Apr 2025. was documented.
Sanchit Sharma was appointed as a Additional Director was appointed as a Additional Director on 12 Feb 2025 & has been associated with this company since 9 months 26 days . was recorded as a recent event.
Progress on A charge registered on 08 Mar 2017 via Charge ID 100088052 with Others was fully satisfied on 15 Jan 2025. was documented.
A charge registered on 30 Jul 2016 via Charge ID 100065493 with Others was fully satisfied on 15 Jan 2025. was recorded as a recent event.
The CIN of Aimil Pharmaceuticals(India) Limited is U24231DL1984PLC019461.
Aimil Pharmaceuticals(India) Limited is headquartered at 2994/4 Street No 17Ranjeet Nagar, New Delhi, Delhi, 110008.
Aimil Pharmaceuticals(India) Limited was incorporated on 30 November 1984.
The current directors of Aimil Pharmaceuticals(India) Limited are
The primary industry of Aimil Pharmaceuticals(India) Limited is Manufacturing.
Aimil Pharmaceuticals(India) Limited is unlisted.
The authorized capital of Aimil Pharmaceuticals(India) Limited is ₹14.50 Cr, and the paid-up capital is ₹11.55 Cr.
The compliance status of Aimil Pharmaceuticals(India) Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX